KURN.SW

Healthcare Medical Devices

Kuros Biosciences AG

CHF 19.01

+0.51 +2.76% today

Price History

Not enough data

Key Stats

Market Cap

754.19M

Avg Volume

200,965

P/E (TTM)

111.82

EPS

CHF 0.17

52W High

CHF 34.20

52W Low

CHF 16.46

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

33.41

P/B Ratio

10.89

P/S Ratio

4.31

EV/EBITDA

55.78

EV/Revenue

4.27

Margins

Gross Margin 86.4%

Operating Margin 5.6%

Net Margin 5.1%

EBITDA Margin 7.6%

Growth & Returns

Revenue Growth (YoY)

45.5%

Return on Equity

10.7%

Return on Assets

5.1%

Liquidity & Leverage

Current Ratio

1.87

Quick Ratio

1.22

Debt / Equity

0.11

Total Cash

9.73M

Total Debt

10.07M

About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

kurosbio.com